Theriva Biologics, Inc. (TOVX) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2010: $532.0K2011: $417.0K2012: $395.0K2013: $1.03M2014: $9.59M2015: $15.84M2016: $20.25M2017: $10.20M2018: $3.69M2019: $5.75M2020: $3.15M2021: $4.96M2022: $17.30M2023: $15.52M2024: $16.29M2025: $22.86M$22.86M
2010Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$22.86M+40.4%
2024$16.29M+4.9%
2023$15.52M-10.3%
2022$17.30M+248.9%
2021$4.96M+57.3%
2020$3.15M-45.2%
2019$5.75M+55.9%
2018$3.69M-63.8%
2017$10.20M-49.7%
2016$20.25M+27.8%
2015$15.84M+65.2%
2014$9.59M+833.6%
2013$1.03M+160.0%
2012$395.0K-5.3%
2011$417.0K-21.6%
2010$532.0K